Hide Board Information

Show Board Information

PD-RX Pharmaceuticals, Inc. PDRX

Board Mod: Add me as mod

Asst Mods:

Last Post: 07/15/2014 6:11:56 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

PD-RX Pharmaceuticals, Inc. PDRX

PD-RX Pharmaceuticals, Inc. (OTCMRKTS: PDRX) Stock Message Board

1. PDRX Company Profile

    

2. PDRX Time & Sales

    

3. PDRX Recent News

    

4. PDRX Filings

    

5. PDRX Financials

    

6. PDRX Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

3	PDRX Financials Tuesday, July 15, 2014 6:11:56 PM	Emylers	07/15/2014 6:11:56 PM
2	PDRX 5.00 Stock Charts $PDRX 1 Month Chart	chartguy89	03/09/2014 4:52:56 AM
1	PDRX Stock Charts Last: +0.20 Friday, February	chartguy89	02/28/2014 10:19:56 PM

Recent Articles

• Piramal Pharma Solutions: New GMP Certificates Enhance Quality
• Piramal Pharma Solutions Accelerates Drug Development Journey
• Exploring xAI's Ambitious Journey to Transform AI into Infrastructure
• Nvidia's Earnings: Anticipating Surprises and Market Reactions
• Walmart Earnings Outlook: Will They Exceed Expectations This Quarter?
• Understanding Nvidia's Earnings and its Impact on the Market
• Elon Musk's Remarkable Return to Washington: Dinner with Trump
• Elon Musk's xAI Seeks $15 Billion to Boost Valuation Significantly
• Essity Secures EcoVadis Platinum Medal for Sustainability Excellence
• HD Hyundai Celebrates Milestone Delivery of 5,000 Ships Globally
• Workday GO: A Game-Changer for Midsize Businesses Empowered
• SkyGrid and High Lander Unite for Air Mobility Innovation
• Workday's Strategic Move: Acquiring Pipedream for Enhanced AI
• Workday Innovates with Global Developer Network and BigQuery
• Cultural Collaboration Between Hunan and Africa Enhances Ties
• Economic Insights on Bladder Cancer Care: New Study Released
• Traders in Asia Seek Stability Amid Market Uncertainty
• Understanding the Transformative $1 Trillion Investment between Trump and MBS
• Exploring the Surge of HBM IP Market: Insights and Projections
• Transforming Marketing Strategies with AI: Insights for CMOs
• Amaroq Ltd. Enhances Financial Flexibility with New Debt Terms
• Taina Kyllönen Joins eQ as Chief People and Communications Officer
• ICG Enterprise Trust Executes Strategic Share Buyback Program
• Atos Unveils Breakthrough AI Solution to Transform Data Engineering
• Recent Share Allocations Highlight Equinor ASA's Growth Strategy
• Williams-Sonoma's Earnings Outlook: Analysts Adjust Estimates
• Essity Achieves EcoVadis Platinum Medal for Sustainability Excellence
• S&P 500 Market Predictions for 2026 and Beyond
• Top 5 Dividend Aristocrats to Consider for Your Portfolio
• Emerging Trends in Loan Demand Signal Banking Sector Growth
• Navigating the Current Market Landscape with AI and Credit Spreads
• NB Private Equity Partners Engages in Significant Share Buyback
• Okeanis Eco Tankers Announces Trading Suspension Reminder
• Foresight Group Holdings Expands Share Buyback Program Efforts
• Equinor's Board Welcomes New Member Jarle Roth for Growth
• Equinor ASA's Share Buy-Back Program: Insights and Updates
• Wereldhave Expands Portfolio with New Shopping Center Purchase
• Exploring Coinbase's Landmark Contribution to Trump's Ballroom
• Mintos Enhances Investor Options with High-Yield Bonds Portfolio
• GEVORKYAN's Exceptional Financial Growth in Q3 2025
• Revolutionizing Healthcare: TruDoc's Super Health App Unveiled
• Michael Burry Questions Baidu's Financial Maneuverings
• Delta and Siemens Form Strategic Partnership for Data Center Solutions
• Delta and Siemens Join Forces to Revolutionize Power Solutions
• The Empowering Growth of the Global Wellness Economy
• Mintos Revolutionizes Investing with New High-Yield Bonds Offering
• Broadridge and Xceptor Innovating Tax Solutions for Finance
• Discover the Future of Visual AI with iniVation's Axiro Lineup
• Understanding Closed Period Notifications and Their Impact
• Wereldhave Expands Portfolio with Ville2 Shopping Center Purchase